BE731207A - - Google Patents

Info

Publication number
BE731207A
BE731207A BE731207DA BE731207A BE 731207 A BE731207 A BE 731207A BE 731207D A BE731207D A BE 731207DA BE 731207 A BE731207 A BE 731207A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE731207A publication Critical patent/BE731207A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Fodder In General (AREA)
BE731207D 1968-04-10 1969-04-08 BE731207A (OSRAM)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72034268A 1968-04-10 1968-04-10
US759516A US3875188A (en) 1968-04-10 1968-09-12 17-Beta-alpha-lower alkyl allene-substituted steroids

Publications (1)

Publication Number Publication Date
BE731207A true BE731207A (OSRAM) 1969-10-08

Family

ID=27110239

Family Applications (1)

Application Number Title Priority Date Filing Date
BE731207D BE731207A (OSRAM) 1968-04-10 1969-04-08

Country Status (11)

Country Link
US (1) US3875188A (OSRAM)
JP (1) JPS4837263B1 (OSRAM)
BE (1) BE731207A (OSRAM)
CA (1) CA953289A (OSRAM)
CH (1) CH522620A (OSRAM)
DE (1) DE1917087A1 (OSRAM)
ES (1) ES365759A1 (OSRAM)
FR (1) FR2007427A1 (OSRAM)
GB (2) GB1273025A (OSRAM)
NL (1) NL6905577A (OSRAM)
SE (1) SE353903B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755860A (fr) * 1970-06-11 1971-02-15 Syntex Corp Propadienyl-steroides alcoyl-substitues en c-17 alpha, nouveauxderives de ceux-ci et procede utilisable pour la preparation de ces composes
US5116830A (en) * 1984-08-17 1992-05-26 Sri International Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses
AU5856090A (en) * 1989-07-07 1991-02-06 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
AU680818B2 (en) * 1992-05-21 1997-08-14 Endorecherche Inc. Improved antiandrogens
PL307333A1 (en) * 1993-05-17 1995-05-15 Endorecherche Inc Improved antiandrogens

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3012045A (en) * 1959-01-22 1961-12-05 Searle & Co 17alpha-alkenyl derivatives of 6alpha-methyl-17beta-hydroxy-19-nor-4-androsten-3-one
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
US3067214A (en) * 1960-04-20 1962-12-04 Merck & Co Inc Haloethisterone compounds
BE665514A (OSRAM) * 1964-06-16
DE1235316B (de) * 1964-11-17 1967-03-02 Schering Ag Verfahren zur Herstellung von 17alpha-AEthinyl-delta 1,3,5(10)-oestratrien-3, 16alpha17beta-triol sowie seiner Ester und AEther
US3318917A (en) * 1965-11-12 1967-05-09 Searle & Co 17alpha-(4-alkoxy-3-buten-1-ynyl)estra-1, 3, 5(10)-triene-3, 17beta-diols and derivatives thereof
US3385871A (en) * 1965-12-15 1968-05-28 Syntex Corp Halogenated cyclopropyl and cyclopropenyl estratrienes and process for their preparation
US3392166A (en) * 1966-03-30 1968-07-09 Syntex Corp Androst-4-enes and estr-4-enes having a 17alpha-diethylenically unsaturated side chain
GB1108276A (en) * 1966-03-14 1968-04-03 British Drug Houses Ltd 17ª‡-alka-1',3'-diynyl-oestra-4,9(10)-dien-3-ones

Also Published As

Publication number Publication date
SE353903B (OSRAM) 1973-02-19
CA953289A (en) 1974-08-20
JPS4837263B1 (OSRAM) 1973-11-09
US3875188A (en) 1975-04-01
NL6905577A (OSRAM) 1969-10-14
DE1917087A1 (de) 1969-11-13
ES365759A1 (es) 1971-03-16
CH522620A (de) 1972-06-30
FR2007427A1 (OSRAM) 1970-01-09
GB1273025A (en) 1972-05-03
GB1273024A (en) 1972-05-03

Similar Documents

Publication Publication Date Title
AU5506869A (OSRAM)
AU2374870A (OSRAM)
AU5184069A (OSRAM)
AU6168869A (OSRAM)
JPS4837263B1 (OSRAM)
AU6171569A (OSRAM)
AU429879B2 (OSRAM)
AU2581067A (OSRAM)
AU4811568A (OSRAM)
AU421558B1 (OSRAM)
AU3224368A (OSRAM)
AU2580267A (OSRAM)
AU4744468A (OSRAM)
AU3789668A (OSRAM)
BE708888A (OSRAM)
BE709138A (OSRAM)
BE727706A (OSRAM)
BE709095A (OSRAM)
BE727301A (OSRAM)
BE726670A (OSRAM)
AU4503667A (OSRAM)
AU2889368A (OSRAM)
AU5758767A (OSRAM)
AU2496167A (OSRAM)
BE724648A (OSRAM)